Partnering for Drug Discovery

The Biodesy Delta™ measures binding-induced structural and conformational changes of biological molecules in real time and high throughput. Utilizing orientation-sensitive second-harmonic generation (SHG) technology, our novel platform enables direct screening for compounds that induce structural changes linked to functional outcomes in targets of interest. Our technology has been applied across a wide range of traditionally challenging targets from RNA to large protein complexes.

We are partnering with other biopharma to jointly discover proprietary assets, focusing on research collaborations that bring together complementary expertise to ensure mutual success.

Partner with Us!